Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Autor: Reid MJA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu., Arinaminpathy N; School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK., Bloom A; Tuberculosis Division, United States Agency for International Development, Washington, DC, USA., Bloom BR; Department of Global Health and Population, Harvard University, Cambridge, MA, USA., Boehme C; Foundation for Innovative New Diagnostics, Geneva, Switzerland., Chaisson R; Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA., Chin DP; Bill & Melinda Gates Foundation, Seattle, WA, USA., Churchyard G; The Aurum Institute, Johannesburg, South Africa., Cox H; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Ditiu L; Stop TB Partnership, Geneva, Switzerland., Dybul M; Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA., Farrar J; The Wellcome Trust, London, UK., Fauci AS; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA., Fekadu E; Volunteer Health Services, Addis Ababa, Ethiopia., Fujiwara PI; Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France., Hallett TB; School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK., Hanson CL; Bill & Melinda Gates Foundation, Seattle, WA, USA., Harrington M; Treatment Action Group, New York, NY, USA., Herbert N; Global TB Caucus, Houses of Parliament, London, UK., Hopewell PC; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Ikeda C; Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan., Jamison DT; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA., Khan AJ; Interactive Research & Development, Karachi, Pakistan., Koek I; Global Health Bureau, United States Agency for International Development, Washington, DC, USA., Krishnan N; Resource Group for Education and Advocacy for Community Health, Chennai, India., Motsoaledi A; South African National Department of Health, Pretoria, South Africa., Pai M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada., Raviglione MC; University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland., Sharman A; Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan., Small PM; Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA., Swaminathan S; WHO, Geneva, Switzerland., Temesgen Z; Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA., Vassall A; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands., Venkatesan N; The Economic Times, Mumbai, India., van Weezenbeek K; KNCV Tuberculosis Foundation, The Haag, Netherlands., Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA., Agins BD; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Alexandru S; Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA., Beyeler N; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA., Bivol S; Center for Health Policies and Studies, Chisinau, Moldova., Brigden G; Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France., Cattamanchi A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Cazabon D; McGill International TB Center, McGill University, Montreal, QC, Canada., Crudu V; Center for Health Policies and Studies, Chisinau, Moldova., Daftary A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada., Dewan P; Bill & Melinda Gates Foundation, New Delhi, India., Doepel LK; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA., Eisinger RW; National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA., Fan V; T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA., Fewer S; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA., Furin J; Division of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA., Goldhaber-Fiebert JD; Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA., Gomez GB; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK., Graham SM; Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia., Gupta D; Revised National TB Control Program, New Delhi, India., Kamene M; National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya., Khaparde S; General TB control, New Delhi, India., Mailu EW; National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya., Masini EO; WHO, Nairobi, Kenya., McHugh L; Office of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland., Mitchell E; International Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland., Moon S; Department of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland., Osberg M; Linksbridge, Seattle, WA, USA., Pande T; McGill International TB Center, McGill University, Montreal, QC, Canada., Prince L; Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA., Rade K; Central Tuberculosis Division, WHO, New Delhi, India., Rao R; Ministry of Health and Family Welfare, New Delhi, India., Remme M; International Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia., Seddon JA; Department of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa., Selwyn C; Bill & Melinda Gates Foundation, Seattle, WA, USA., Shete P; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Sachdeva KS; Revised National TB Control Program, New Delhi, India., Stallworthy G; Seattle, WA, USA., Vesga JF; School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK., Vilc V; National TB Program, WHO, Chisinau, Moldova., Goosby EP; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.

Publikováno v: Lancet (London, England) [Lancet] 2019 Mar 30; Vol. 393 (10178), pp. 1331-1384. Date of Electronic Publication: 2019 Mar 20.

Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study.

Autor: Nguyen, Hoa Binh¹ (AUTHOR), Vo, Luan Nguyen Quang^2,3 (AUTHOR) luan.vo@tbhelp.org, Forse, Rachel Jeanette^2,3 (AUTHOR), Wiemers, Anja Maria Christine² (AUTHOR), Huynh, Huy Ba² (AUTHOR), Dong, Thuy Thi Thu² (AUTHOR), Phan, Yen Thi Hoang² (AUTHOR), Creswell, Jacob⁴ (AUTHOR), Dang, Thi Minh Ha⁵ (AUTHOR), Nguyen, Lan Huu⁵ (AUTHOR), Shedrawy, Jad³ (AUTHOR), Lönnroth, Knut³ (AUTHOR), Nguyen, Tuan Dinh¹ (AUTHOR), Dinh, Luong Van¹ (AUTHOR), Annerstedt, Kristi Sidney³ (AUTHOR), Codlin, Andrew James^2,3 (AUTHOR)

Publikováno v: Infectious Diseases of Poverty. 3/25/2024, Vol. 13 Issue 1, p1-12. 12p.

Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.

Autor: Fekadu L; Federal Ministry of Health, Tuberculosis and Leprosy Disease Prevention and Control Team, Addis Ababa, Ethiopia., Hanson C; Macalester College, St. Paul, Minnesota.; Bill and Melinda Gates Foundation., Osberg M; Linksbridge, Seattle, Washington., Makayova J; Macalester College, St. Paul, Minnesota., Mingkwan P; Macalester College, St. Paul, Minnesota., Chin D; Bill and Melinda Gates Foundation.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2017 Nov 06; Vol. 216 (suppl_7), pp. S696-S701.

Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.

Autor: Garfin C; Department of Health of the Philippines, National Tuberculosis Program., Mantala M; Technical Assistance to Country project., Yadav R; World Health Organization, Office of the Philippines, Manila., Hanson CL; Macalester College, St. Paul, Minnesota.; Bill and Melinda Gates Foundation., Osberg M; Linksbridge, Seattle, Washington., Hymoff A; Macalester College, St. Paul, Minnesota., Makayova J; Macalester College, St. Paul, Minnesota.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2017 Nov 06; Vol. 216 (suppl_7), pp. S740-S747.

Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.

Autor: Surya A; Subdirectorate of Tuberculosis, Ministry of Health, Jakarta., Setyaningsih B; Subdirectorate of Tuberculosis, Ministry of Health, Jakarta., Suryani Nasution H; Subdirectorate of Tuberculosis, Ministry of Health, Jakarta., Gita Parwati C; Challenge TB Project, KNCV Tuberculosis Foundation, Jakarta, Indonesia., Yuzwar YE; Subdirectorate of Tuberculosis, Ministry of Health, Jakarta., Osberg M; Linksbridge, Seattle, Washington., Hanson CL; Macalester College, St Paul, Minnesota.; Bill & Melinda Gates Foundation, Seattle, Washington., Hymoff A; Macalester College, St Paul, Minnesota., Mingkwan P; Macalester College, St Paul, Minnesota., Makayova J; Macalester College, St Paul, Minnesota., Gebhard A; Challenge TB Project, KNCV Tuberculosis Foundation, Jakarta, Indonesia., Waworuntu W; Directorate of Prevention and Control of Communicable Disease, Ministry of Health, Jakarta, Indonesia.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2017 Nov 06; Vol. 216 (suppl_7), pp. S724-S732.